Molecular and Clinical Risk-Directed Therapy for Infants and Young Children With Newly Diagnosed Medulloblastoma | ClinicalTrials HQ

Ask about research services

Swipe the table sideways for more columns.

Trial	Conditions	Status	Phase	Updated	More info	NCT ID
Molecular and Clinical Risk-Directed Therapy for Infants and Young Children With Newly Diagnosed Medulloblastoma	Neoplasms by Histologic Type, Neoplasms by Site, Neoplasms, Germ Cell and Embryonal, Neoplasms, Nerve Tissue, Neuroectodermal Tumors, Primitive, brain disorder, central nervous system cancer, central nervous system disorder, epithelial neoplasm, glioma, medulloblastoma, neoplasm, nervous system disorder, neuroepithelial neoplasm, primitive neuroectodermal tumor	Recruiting	Phase 2	2026-09-15		NCT05535166

2 results · Page 1 of 1

Swipe the table sideways for more columns.

Organizations	Linked trials
National Cancer Institute (NCI)	3015
St. Jude Children's Research Hospital	169

10 results · Page 1 of 1

Swipe the table sideways for more columns.

Research sites	City	Country	Linked trials
C.S. MOTT Children's Hospital, University of Michigan	Ann Arbor	United States	2
Children's Hospital and Clinics of Minnesota	Minneapolis	United States	10
Cook Children's Medical Center	Fort Worth	United States	111
Lucille Packard Children's Hospital Stanford	Palo Alto	United States	2
Orlando Health Arnold Palmer Hospital for Children	Orlando	United States	4
Primary Children's Hospital	Salt Lake City	United States	111
St. Joseph's Children's Hospital	Tampa	United States	4
St. Jude Children's Research Hospital	Memphis	United States	194
Texas Children's Hospital	Houston	United States	1
UT Southwestern Medical Center/Harold C Simmons Comprehensive Cancer Center	Dallas	United States	1